Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Diosgenin as a Novel Alternative Therapy for Inhibition of Growth, Invasion, and Angiogenesis Abilities of Different Glioblastoma Cell Lines

Neurochemical Research(2020)10.1007/s11064-020-03093-0Source: DataRank Database

Diosgenin as a Novel Alternative Therapy for Inhibition of Growth, Invasion, and Angiogenesis Abilities of Different Glioblastoma Cell Lines is a research paper published in Neurochemical Research (2020). On theSindex it has a DataRank of 0. It has been cited 37 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access37 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.97)OA: bronzeTopics (51)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Swapan K. Ray ORCID,Firas Khathayer ORCID

Live enrichment

PubMed:32683533 OpenAlex:https://openalex.org/W3042497893

National Cancer Institute

Grant: CA-091460

National Institute of Neurological Disorders and Stroke

Grant: NS-057811

National Institutes of Health

Grant: 7R01CA091460-06

PROTEOLYTIC CONTROL OF GLIOBLASTOMA

National Institutes of Health

Grant: 7R01NS057811-03

DIFFERENTIATION AND APOPTOSIS IN MALIGNANT NEUROBLASTOMA

FWCI

0.97

Citation Percentile

0.7%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: Springer TDM

journalhttps://link.springer.com/content/pdf/10.1007/s11064-020-03093-0.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s11064-020-03093-0.pdf

publisherhttps://link.springer.com/article/10.1007/s11064-020-03093-0/fulltext.html

journalhttps://doi.org/10.1007/s11064-020-03093-0

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32683533

Fields of Study

Phytochemical Studies and BioactivitiesPhytochemistry and Bioactive CompoundsMarine Sponges and Natural Products0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsAntineoplastic AgentsCell MovementCell SurvivalDiosgeninGlioblastomaHumansApoptosisProto-Oncogene Proteins c-bcl-2Angiogenesis InhibitorsMatrix Metalloproteinase 2Matrix Metalloproteinase 9Cell Line, TumorCell Proliferationbcl-2-Associated X ProteinRats

Keywords

DiosgeninMMP2AngiogenesisCell growthApoptosisCancer researchBiologyCell culturePharmacologyCell biologyMetastasisCancerBiochemistryDifferentiationInvasionGlioblastomaCell SurvivalAngiogenesis InhibitorsAntineoplastic AgentsRatsMatrix Metalloproteinase 9Proto-Oncogene Proteins c-bcl-2Cell MovementCell Line, TumorAnimalsHumansMatrix Metalloproteinase 2Cell Proliferationbcl-2-Associated X Protein

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Zero hunger